期刊文献+

中西医结合治疗输卵管性不孕 被引量:1

Integrated Treatment of Tubal Infertility
下载PDF
导出
摘要 目的探讨输卵管性不孕的治疗方法,提高其妊娠率。方法对2003年1月~2005年12月来我院就诊的不孕症患者中,患输卵管不畅、阻塞(输卵管性不孕)的患者,对采用输卵管内注药,配合口服止痛化徵胶囊加中药抗炎通管汤保留灌肠治疗的妊娠率与输卵管通畅的妊娠率进行比较;在此基础上,研究输卵管异常合并痛经、子宫内膜异位症的情况。结果①输卵管性不孕患者治疗后的妊娠率为38.63%,与输卵管通畅患者的妊娠率44.33%相近,差异无统计学意义(P>0.05);②子宫内膜异位症患者输卵管异常发生率为80.56%,痛经患者输卵管异常发生率为59.91%;③子宫内膜异位症患者输卵管异常治疗后妊娠率为31.03%,痛经患者输卵管异常治疗后妊娠率为42.11%。结论通过中西医结合治疗输卵管性疾病,可以使40%以上的输卵管性不孕患者妊娠,疗效肯定,安全易行,有其临床实用性,适合基层医院。 Objective To study the treatment of tubal infertility, and improve their pregnancy rate. Methods From January 2003 to December 2005 to our hospital infertility patients, suffering from poor oviduct, blocking ( tubal infertility ), the use of injection drugs within the oviduct, with signs of oral pain of anti-Chinese Herbal Medicine Capsule Yan Tong Tang retention enema tube. Then studied the fallopian tube abnormalities combined dysmenorrhea, endometriosis situation. Results (1)Treatment of tubal infertility after tubal pregnancy rate was 38.63% and 44.33% pregnancy rate in patients with unobstructed similar difference was not statistically significant ( P 〉 0.05 ). (2) Endometriosis patients with tubal abnormalities the incidence of 80.56%, while the incidence of tubal abnormalities in patients with dysmenorrhea 59.91%. (3)Endometriosis patients with abnormal tubal pregnancy rate was 31.03% after treatment, while dysmenorrhea in patients with abnormal tubal pregnancy rate was 42.11% after treatment. Conclusion Integrative Medicine by tubal disease, can make over 40% of tubal infertility pregnancy, more effective, safe, easy and has its clinical relevance for primary hospital.
作者 王彩虹
出处 《中国现代医生》 2011年第23期149-150,共2页 China Modern Doctor
关键词 输卵管性不孕 保留灌肠 中药 Tubal Infertility Retention enema Chinese Medicine
  • 相关文献

参考文献6

二级参考文献29

  • 1许燕雪,张友忠.女性不孕症病因研究的进展[J].现代妇产科进展,1995,4(4):365-368. 被引量:22
  • 2王肖平,杜红巧,朱庆义,唐续元.应用聚合酶链反应技术检测自然流产组织中解脲支原体[J].中华妇产科杂志,1996,31(2):112-112. 被引量:24
  • 3Berkkanoglu M,Arici A.Immunology and endometriosis[J].American Journal of Reproductive Immunology,2003,50(1):48 -59.
  • 4Halme J,Becker S,Wing R.Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis[J].American Journal of Obstetrics and Gynecology,1984,148(1):85 -90.
  • 5Nothnick WB,Curry TE,Vernon MW.Immunomodulation of rat endometriotic implant growth and protein production[J].American Journal of Reproductive Immunology,1994,31 (2-3):151-162.
  • 6Steinleitner A,Lambert H,Roy S.Immunomodulation with pentoxifylline abrogates macrophage-mediated infertility in an in vivo model:a paradigm for a novel approach to the treatment of endome triosis associated subfertility[J].Fertility and Sterility,1991,55 (1):26-31.
  • 7Creus M,Fabregues F,Carmona F,et al.Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-associated infertility:A preliminary trial[J].Human Reproduction,2008,23(8):1910 -1916.
  • 8Balasch J,Creus M,Fabregues F,et al.Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis:a pilot randomized clinical trial[J].Human reproduction,1997,12(9):2046 -2050.
  • 9Alborzi S,Ghotbi S,Parsanezhad ME,et al.Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis:a prospective,double-blind,randomized,placebo-controlled study[J].Journal of minimally invasive gynecology,2007,14(1):54-58.
  • 10Kamencic H,Thiel JA.Pentoxifylline after conservative surgery for endometriosis:a randomized,controlled trial[J].Journal of minimally invasive gynecology,2008,15 (1):62-66.

共引文献262

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部